Methyl salicylate / Sweet Birch oil / AntiBio Cancer Research Results

MeSal, Methyl salicylate / Sweet Birch oil: Click to Expand ⟱
Features:

Methyl salicylate / Sweet Birch oil — Methyl salicylate is a small lipophilic salicylate ester and the dominant constituent of sweet birch oil and wintergreen oil. It is best classified as a natural-product-derived topical counterirritant / salicylate prodrug rather than a practical systemic anticancer agent. Natural sources include Betula lenta sweet birch and Gaultheria procumbens wintergreen, but commercial methyl salicylate is also commonly synthetic. Its cancer relevance is mainly mechanistic and indirect through salicylate biology, with major translation limits from toxicity, dermal absorption variability, and the high millimolar concentrations used in many cell studies.

Primary mechanisms (ranked):

  1. Hydrolysis to salicylate / salicylic acid, linking methyl salicylate to salicylate pharmacology rather than a distinct validated anticancer modality.
  2. COX and prostaglandin-axis suppression, reducing inflammatory signaling that can support tumor promotion and pain/inflammation pathways.
  3. NF-κB pathway inhibition, with potential suppression of survival, inflammatory, invasion, and therapy-resistance signaling in cancer contexts.
  4. AMPK activation with downstream c-MYC suppression and NRF2/ARE/miR-34a/b/c activation, reported for salicylate in colorectal cancer models.
  5. p38 MAPK-linked apoptosis and cell-cycle effects, mostly from sodium salicylate studies at pharmacologic-to-high in-vitro concentrations.
  6. Secondary mitochondrial stress / oxidative phosphorylation disruption at toxic or high concentrations, more relevant to safety than selective anticancer translation.

Bioavailability / PK relevance: Methyl salicylate is lipophilic and can penetrate skin; dermal absorption and systemic salicylate exposure are strongly formulation-, area-, dose-, heat-, and occlusion-dependent. It is rapidly hydrolyzed to salicylate, so systemic effects and toxicity resemble salicylate exposure. Oral or concentrated essential-oil exposure is a major toxicity concern and should not be treated as a supplement-like route.

In-vitro vs systemic exposure relevance: Many anticancer mechanistic studies use sodium salicylate or salicylate at millimolar concentrations, which generally exceed realistic or safe exposure targets for methyl salicylate oil. Topical use can create local tissue exposure and systemic salicylate exposure, but this is not a controlled anticancer delivery strategy. Mechanistically relevant but clinically constrained.

Clinical evidence status: Cancer evidence is preclinical / indirect, mostly extrapolated from salicylate and aspirin biology rather than methyl salicylate as an anticancer intervention. Human evidence supports topical analgesic / counterirritant use, not cancer treatment. Regulatory deployment is OTC topical analgesic/counterirritant in some jurisdictions and cosmetic/fragrance ingredient under concentration limits, with important salicylate toxicity, skin burn/irritation, sensitization, renal disease, anticoagulant, and pediatric safety constraints.

Methyl Salicylate Mechanistic Ranking

Rank Pathway / Axis Cancer Cells Normal Cells TSF Primary Effect Notes / Interpretation
1 Salicylate prodrug conversion ↔ methyl salicylate-specific targeting; ↑ salicylate exposure after hydrolysis ↑ systemic salicylate burden after dermal or oral exposure R Functional conversion to salicylate biology Most mechanistic cancer claims should be attributed to salicylate / salicylic acid rather than sweet birch oil as a complex essential oil.
2 COX prostaglandin inflammatory signaling ↓ prostaglandin-linked inflammatory support (context-dependent) ↓ inflammatory pain signaling; potential platelet / renal / gastric salicylate constraints if systemic R-G Anti-inflammatory counterirritant / salicylate effect Relevant to tumor-promoting inflammation but not a selective anticancer mechanism.
3 NF-κB survival and inflammatory signaling ↓ NF-κB activation; ↑ TNF-linked apoptosis in some cancer models ↓ inflammatory gene expression; possible impaired protective inflammatory responses R-G Reduced survival and inflammatory transcription Evidence is strongest for salicylate / aspirin class biology, not methyl salicylate oil itself.
4 AMPK c-MYC NRF2 miR-34 cascade ↑ AMPK; ↓ c-MYC; ↑ NRF2/ARE; ↑ miR-34a/b/c; ↓ migration / invasion in colorectal cancer models ↑ AMPK metabolic signaling (context-dependent) G Metabolic and tumor-suppressive microRNA modulation Mechanistically interesting for colorectal cancer, but based on salicylate concentrations that may not be safely achievable from methyl salicylate oil.
5 p38 MAPK apoptosis ↑ p38 MAPK; ↑ apoptosis (high concentration only) ↑ stress-response apoptosis risk at toxic exposure R-G Stress-activated apoptosis Useful as a mechanistic flag, but selectivity is uncertain and concentration dependence is a major limitation.
6 Mitochondrial stress and oxidative phosphorylation disruption ↑ metabolic stress (toxic concentration only) ↑ systemic toxicity risk; acid-base disturbance risk with overdose R-G Toxic salicylate pharmacology This is mainly a safety constraint rather than a therapeutic anticancer mechanism.
7 Clinical Translation Constraint ↔ no validated anticancer exposure strategy ↑ dermal absorption variability; ↑ toxicity risk with ingestion, damaged skin, large-area use, heat, occlusion, renal disease, anticoagulants, or aspirin sensitivity R-G Translation limited by toxicity and exposure control Best database placement is “mechanistic / preclinical salicylate-related,” not an actionable cancer therapy listing.

TSF legend: P: 0–30 min R: 30 min–3 hr G: >3 hr
AntiBio, Antibiotic/Antimicrobial activity: Click to Expand ⟱
Source:
Type:

Antibiotic / antimicrobial activity: The ability of a substance to suppress or kill microorganisms, especially bacteria, by disrupting microbial survival, growth, biofilm formation, cell-wall integrity, membrane function, protein synthesis, nucleic-acid synthesis, quorum sensing, or virulence.

Natural Products that might have antimicrobial properties

Natural supplement or product Principal constituents Potential antimicrobial activity Evidence assessment Reference
Garlic
Allium sativum		 Allicin, ajoene and diallyl sulfides Antibacterial and antifungal activity, with some antiviral and antiparasitic effects reported in laboratory studies. Extensive laboratory evidence, but insufficient clinical evidence to use garlic as a treatment for established infections. Tesfaye A. Revealing the therapeutic uses of garlic and its potential for drug discovery. Scientific review.
Berberine Berberine isoquinoline alkaloid May damage bacterial membranes, inhibit efflux pumps, interfere with nucleic-acid and protein synthesis, and inhibit biofilm formation. Strong preclinical evidence and limited indication-specific clinical evidence. Poor oral bioavailability and drug interactions limit its use as a general antimicrobial. Berberine as a therapeutic alkaloid against ESKAPE and multidrug-resistant bacteria: a comprehensive review.
Cranberry extract
Vaccinium macrocarpon		 A-type proanthocyanidins Primarily reduces adhesion of uropathogenic bacteria, particularly Escherichia coli, to urinary epithelial cells. May reduce recurrent urinary tract infections in selected populations. It is preventive rather than a reliable treatment for an active UTI. National Center for Complementary and Integrative Health: Cranberry—Usefulness and Safety.
Probiotics
Lactobacillus, Bifidobacterium and Saccharomyces boulardii 		Live microorganisms; effects are strain-specific Competitive exclusion of pathogens, production of bacteriocins, inhibition of pathogen adhesion and restoration of microbiome function. Some human evidence for antibiotic-associated diarrhea and selected gastrointestinal or vaginal indications. Results cannot be generalized from one strain to another. NIH Office of Dietary Supplements: Probiotics—Health Professional Fact Sheet.
Medical-grade honey / Manuka honey Methylglyoxal, hydrogen peroxide, defensin-1, organic acids and high osmolarity Broad topical antibacterial and antibiofilm activity; also supports autolytic debridement and wound healing. Clinically relevant primarily as a standardized, medical-grade topical wound product. Ordinary food honey is not equivalent. Jull AB et al. Honey as a topical treatment for wounds. Cochrane systematic review.
Oregano oil
Origanum vulgare		 Carvacrol and thymol Antibacterial, antifungal and antibiofilm activity, largely through disruption of microbial membranes. Strong laboratory activity, but inadequate human evidence for oral treatment of infections. Concentrated oil can cause irritation. Chemical composition, biological activity and potential uses of oregano and oregano essential oil: a review.
Thyme
Thymus vulgaris		 Thymol and carvacrol Antibacterial, antifungal and antibiofilm activity through membrane damage and altered microbial permeability. Better established as a constituent of topical antiseptic and oral-care formulations than as an oral treatment for systemic infection. PubMed literature: thyme, thymol and antimicrobial activity.
Tea tree oil
Melaleuca alternifolia		 Terpinen-4-ol and related monoterpenes Topical antibacterial and antifungal activity with some antiviral laboratory activity. Some clinical evidence for topical acne and fungal skin conditions. Tea tree oil is toxic when swallowed and may cause contact dermatitis. Carson CF et al. Melaleuca alternifolia oil: a review of antimicrobial and other medicinal properties.
Echinacea
Echinacea species		 Alkamides, caffeic-acid derivatives, polysaccharides and glycoproteins Primarily immunomodulatory; relatively weak and inconsistent direct antimicrobial activity. Evidence for preventing or shortening respiratory infections is inconsistent and preparation-dependent. National Center for Complementary and Integrative Health: Echinacea—Usefulness and Safety.
Elderberry
Sambucus nigra		 Anthocyanins, flavonols and phenolic acids Antiviral effects have been reported in cell-culture and preclinical studies, including interference with viral entry or replication. Small human trials have examined respiratory symptoms, but evidence remains insufficient to establish treatment of influenza or other viral infections. National Center for Complementary and Integrative Health: Elderberry.
Curcumin / turmeric
Curcuma longa		 Curcumin and related curcuminoids Antibacterial, antifungal, antiviral and antibiofilm activity through multiple membrane, enzyme and signalling effects. Predominantly laboratory evidence. Poor aqueous solubility and low systemic bioavailability are major clinical limitations. Moghadamtousi SZ et al. A review on antibacterial, antiviral and antifungal activity of curcumin.
Ginger
Zingiber officinale		 Gingerols, shogaols and zingerone Antibacterial and antifungal activity, including possible inhibition of microbial adhesion and biofilm formation. Primarily laboratory evidence; there is little direct clinical evidence that ginger supplements treat infections. PubMed literature: ginger, gingerols and antimicrobial activity.
Clove
Syzygium aromaticum		 Eugenol and eugenyl acetate Antibacterial, antifungal and local antiseptic activity, principally through membrane and protein disruption. Relevant mainly to topical, food-preservation and dental applications. Evidence for systemic infection treatment is insufficient. PubMed literature: clove, eugenol and antimicrobial activity.
Cinnamon
Cinnamomum species		 Cinnamaldehyde, eugenol and cinnamic acid derivatives Antibacterial, antifungal and antibiofilm activity; may alter microbial membranes and quorum-sensing pathways. Predominantly laboratory evidence. Cassia cinnamon can contribute substantial coumarin exposure when consumed in concentrated amounts. PubMed literature: cinnamon, cinnamaldehyde and antimicrobial activity.
Neem
Azadirachta indica		 Nimbidin, nimbin, nimbolide, azadirachtin and other limonoids Antibacterial, antifungal, antiparasitic and antibiofilm effects have been reported. Some topical and dental research exists, but systemic clinical evidence is inadequate. Oral neem preparations have important safety concerns. PubMed literature: Azadirachta indica and antimicrobial activity.
Black seed
Nigella sativa		 Thymoquinone, thymohydroquinone and related volatile compounds Antibacterial, antifungal, antiparasitic and possible antiviral activity. Considerable laboratory research but limited, heterogeneous clinical evidence for infectious diseases. PubMed literature: Nigella sativa, thymoquinone and antimicrobial activity.
Green tea extract
Camellia sinensis		 Epigallocatechin gallate (EGCG) and other catechins Antibacterial, antiviral and antibiofilm activity; may damage membranes, inhibit microbial enzymes and enhance some antibiotics. Some localized oral-health evidence, but limited evidence for treating systemic infections. Concentrated extracts may cause liver injury in susceptible individuals. PubMed literature: EGCG, green tea and antimicrobial activity.
Licorice root
Glycyrrhiza species		 Glycyrrhizin, glycyrrhetinic acid, liquiritigenin and other flavonoids Antiviral, antibacterial and antifungal effects have been reported in laboratory and preclinical studies. Limited clinical antimicrobial evidence. Glycyrrhizin can cause hypertension, hypokalemia, fluid retention and clinically important drug interactions. National Center for Complementary and Integrative Health: Licorice Root.
Andrographis
Andrographis paniculata		 Andrographolide and related diterpenoid lactones Immunomodulatory, anti-inflammatory and possible antiviral or antibacterial activity. Some evidence for modest symptom reduction in uncomplicated respiratory infections, but this does not establish direct pathogen eradication. PubMed literature: Andrographis and respiratory infections.
Pelargonium sidoides Proanthocyanidins, phenolic acids and oxygenated coumarin derivatives Possible antiviral, antibacterial anti-adhesive and immunomodulatory activity. Some human evidence for modest symptom improvement in acute bronchitis and selected respiratory infections. It is not a substitute for antibiotics when bacterial treatment is indicated. Timmer A et al. Pelargonium sidoides extract for acute respiratory tract infections. Cochrane systematic review.
Monolaurin
Glycerol monolaurate		 Monolaurin, a monoester derived from lauric acid May disrupt lipid membranes and interfere with signalling or virulence in certain bacteria and enveloped viruses. Predominantly laboratory and animal evidence. There is insufficient clinical evidence to recommend oral monolaurin for infections. PubMed literature: glycerol monolaurate and antimicrobial activity.
Caprylic acid Octanoic acid, an eight-carbon medium-chain fatty acid Antifungal and membrane-disrupting activity, particularly against Candida species, has been reported in vitro. Insufficient human evidence for treating candidiasis or systemic fungal infection. Marketing claims commonly exceed the evidence. PubMed literature: caprylic acid and Candida.
Olive leaf extract
Olea europaea		 Oleuropein, hydroxytyrosol and elenolic-acid derivatives Antibacterial, antiviral and antifungal activity has been observed in laboratory studies. Preliminary evidence only; clinical trials have not established it as a treatment for infectious disease. PubMed literature: olive leaf, oleuropein and antimicrobial activity.
Goldenseal
Hydrastis canadensis		 Hydrastine, canadine and berberine Extracts and individual alkaloids show antibacterial activity in laboratory studies. There is no good clinical evidence that goldenseal treats human infections. Product composition, absorption and drug interactions are important limitations. National Center for Complementary and Integrative Health: Goldenseal.
Sweet wormwood / artemisinin
Artemisia annua 		Artemisinin and related sesquiterpene lactones Artemisinin derivatives are potent antimalarial agents. Additional antibacterial, antiviral and antiparasitic effects are being studied. Artemisinin-based combination therapies are established medicines, not ordinary supplements. Herbal preparations should not replace standardized malaria treatment because dose variability can promote treatment failure and resistance. World Health Organization: Guidelines for malaria.

Evidence interpretation

  • Clinical evidence: Effects have been studied in human participants, but usually for a specific preparation, route, dose and indication.
  • Preclinical evidence: Activity has mainly been demonstrated in cell culture, microbial cultures or animal models.
  • Anti-adhesive or probiotic activity: The product may reduce colonization or pathogen attachment without directly killing the microorganism.
  • Topical evidence: Results from topical use cannot be assumed to apply to an orally administered supplement.


Scientific Papers found: Click to Expand⟱
6535- MeSal,    Phytochemistry and Biological Profile of Gaultheria procumbens L. and Wintergreen Essential Oil: From Traditional Application to Molecular Mechanisms and Therapeutic Targets
*Inflam↓, *antiOx↑, *AntiBio↑, *other↝,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

AntiBio↑, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

other↝, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

Inflam↓, 1,  
Total Targets: 4

Scientific Paper Hit Count for: AntiBio, Antibiotic/Antimicrobial activity
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:412  Target#:1483  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page